Agios Pharmaceuticals Inc Bennfentes tulajdonlás
Mi az Agios Pharmaceuticals Inc Bennfentes tulajdonlás?
A Bennfentes tulajdonlás az Agios Pharmaceuticals Inc - 1.35%
Mi a Bennfentes tulajdonlás meghatározása?
A bennfentes tulajdonjog kiszámítása a bennfentesek tulajdonában lévő részvények (részvényesek, akik a vállalat több mint 5% -át, vagy a vállalat tisztségviselőjét vagy igazgatóját birtokolják) teljes létszámával, osztva a teljes részvénykivonással.
A high value of insider ownership means that those working for the company have a large stake in the success of the company. This is sometimes seen as a sign that those running the company will work hard to ensure its success or believe the company's stock price will rise.
A change in insider ownership may come from exercise of option, stock grant and buying or selling of company shares. A purchase of company share signifies a confidence in the company's future performance by people who know the company best. Therefore, Net Insider buying is also an important indicator for investors.
Bennfentes tulajdonlás a Health Care szektor a NASDAQ-on cégekben a Agios Pharmaceuticals Inc -hoz képest
Mit csinál Agios Pharmaceuticals Inc?
at agios, we are doing incredibly important and difficult work. we are trying to discover and develop breakthrough medicines, and we have a clear motivator — people with cancer and rare genetic diseases who are counting on us to be successful. we are a science-driven research organization. we have built a discovery platform upon our expertise in the fields of cellular metabolism and precision medicine across three major focus areas: cancer metabolism, rare genetic metabolic disorders and metabolic immuno-oncology. it takes people with a diversity of thought, skills, passions and backgrounds to get us from the first stages of understanding new biology and discovering drugs to our ultimate goal of getting these medicines to patients who are waiting for them. our connection to one another and our work and our commitment to our values enable us to potentially change the practice of medicine by by striving for excellence and doing things differently. we call this the "other side of possible
bennfentes tulajdonlás -hoz hasonló cégek Agios Pharmaceuticals Inc
- Blucora Inc nak Bennfentes tulajdonlás 1.34% van
- Genworth Inc nak Bennfentes tulajdonlás 1.34% van
- Intercontinental Exchange nak Bennfentes tulajdonlás 1.34% van
- Genprex Inc nak Bennfentes tulajdonlás 1.34% van
- Intercontinental Exch.Inc nak Bennfentes tulajdonlás 1.34% van
- Collegium Pharmaceutical Inc nak Bennfentes tulajdonlás 1.34% van
- Agios Pharmaceuticals Inc nak Bennfentes tulajdonlás 1.35% van
- Dnow Inc nak Bennfentes tulajdonlás 1.35% van
- Bonanza Creek Inc nak Bennfentes tulajdonlás 1.35% van
- Wajax nak Bennfentes tulajdonlás 1.35% van
- RiverNorth Opportunities Fund Inc nak Bennfentes tulajdonlás 1.35% van
- Sonos Inc nak Bennfentes tulajdonlás 1.35% van
- NetEase Inc nak Bennfentes tulajdonlás 1.35% van